Today: 9 June 2026
NatWest share price: fresh forecasts and buyback update set up Feb 13 results
23 January 2026
2 mins read

NatWest share price: fresh forecasts and buyback update set up Feb 13 results

LONDON, Jan 23, 2026, 08:59 GMT — Regular session.

  • NatWest shares saw minimal movement in early London trading
  • Ahead of its annual results, the bank released revised sell-side forecasts
  • Investors are focused on rates, profit margins, and how quickly companies are buying back shares

Shares in NatWest Group Plc (NWG.L) nudged 0.06% higher to roughly 654 pence by 0859 GMT, following fresh analyst forecasts released ahead of next month’s earnings report and additional buyback announcements. The stock fluctuated between 650.2 and 657.6 pence.

NatWest’s latest pre-results “consensus”—a company-compiled snapshot of sell-side estimates—puts 2025 operating profit before tax at £7.49 billion, based on forecasts from 16 analysts. The consensus pegs the net interest margin at 2.32% for 2025, with a Common Equity Tier 1 (CET1) ratio of 13.7%, the key capital metric regulators watch. NatWest Group Investors

This is significant as NatWest’s full-year results arrive amid a turbulent climate for UK banks: rate-cut expectations are swinging daily, and investors wonder how long last year’s hefty deposit margins will last. Capital returns also play a key role; a consistent buyback program can support earnings per share even if profits take a hit.

Net interest margin—the difference between what banks earn on loans and what they pay on deposits, relative to their interest-earning assets—is a narrow percentage. Yet, it fuels much of the discussion about bank profits whenever rates shift.

A U.S. filing revealed NatWest repurchased 811,319 shares on Jan. 22 at a volume-weighted average price of 654.46 pence, with individual trades ranging from 645.40 to 663.80 pence. The bank acquired the shares from Merrill Lynch International (Bank of America) and confirmed plans to cancel them.

NatWest bought back 830,691 shares the previous day at an average price of 647.34 pence, according to a London announcement, with plans to cancel them. Both moves took place on the London Stock Exchange under the bank’s current buyback scheme.

Risk appetite remains fragile. UK stocks edged up Thursday as U.S. President Donald Trump eased off his Greenland comments and investors clung to optimism over a possible Ukraine deal. The FTSE 100 gained 0.1%, while the FTSE 250 climbed 1.3%.

European stocks dipped on Friday, heading for a weekly drop amid concerns over Greenland-related trade frictions and fresh purchasing managers’ data. Economists at ING noted these surveys “are likely to confirm the ongoing resilience of the euro zone’s gradual recovery despite geopolitical headwinds.” Reuters

Retail sales in Britain climbed 0.4% in December, surpassing predictions and stirring speculation about the Bank of England’s upcoming decision. The Office for National Statistics noted, “Non-store retailers rebounded, with online jewellers confirming renewed demand for precious metals.” Reuters

The downside is clear. Quicker rate cuts would tighten margins, while a slip in jobs or housing could push up credit losses — the income statement item that can shift rapidly for a UK-focused lender.

NatWest’s annual results, due Feb. 13, will drop at 7 a.m. GMT, with investor sessions lined up throughout the morning and afternoon. The bank has flagged it will unveil 2026 guidance and fresh targets for 2028 alongside the numbers.

Stock Market Today

  • Trump Bull Market May End Soon, But Eli Lilly and Johnson & Johnson Set to Thrive
    June 8, 2026, 7:26 PM EDT. The S&P 500 surged over 23% since Trump's inauguration, fueled by sectors like AI and tech. However, high valuation metrics and inflation pose risks, suggesting the Trump bull market could end soon. Despite this, pharmaceutical giants Eli Lilly and Johnson & Johnson are positioned to continue growth. Eli Lilly leads the obesity drug market with products like Mounjaro and Zepbound, showing strong revenue gains and advancing new treatments. Johnson & Johnson benefits from its diversified healthcare portfolio, providing stability amid economic uncertainties. Investors may find these stocks resilient as broader market gains face headwinds.

Latest articles

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Peso Rebounds, But Mexico’s Next Inflation Print Looms

Peso Rebounds, But Mexico’s Next Inflation Print Looms

9 June 2026
Mexico’s peso edged up 0.09% to 17.4644 per dollar after Iran and Israel paused attacks, but traders turned cautious ahead of Tuesday’s Mexico inflation data, which could shape Banxico rate expectations and impact the peso’s yield advantage that has supported the currency.
T1 Energy Shares Dip After KORE Power Files New Update

T1 Energy Shares Dip After KORE Power Files New Update

9 June 2026
T1 Energy shares slid 3.2% to $9.13 after a new SEC filing revealed up to $24.7 million in stock-linked payments for its $32 million KORE Power acquisition, spotlighting dilution risks as the company expands into battery storage and data-center power; the deal’s structure and timing come as T1 seeks growth funding and investors weigh near-term costs against future EBITDA targets.
British American Tobacco share price in focus before London open after buyback disclosure
Previous Story

British American Tobacco share price in focus before London open after buyback disclosure

Experian share price rebounds after bruising slide as traders weigh Q3 update and policy risk
Next Story

Experian share price rebounds after bruising slide as traders weigh Q3 update and policy risk

Go toTop